The DOI matches its Crossref record; 226 of the 226 references it cites were found in a registry or an index.
Iron in Neurodegeneration – Cause or Consequence?
Open accessAbstract
Iron dyshomeostasis can cause neuronal damage to iron-sensitive brain regions. Neurodegeneration with brain iron accumulation reflects a group of disorders caused by iron overload in the basal ganglia. High iron levels and iron related pathogenic triggers have also been implicated in sporadic neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease (PD), and multiple system atrophy (MSA). Iron-induced dyshomeostasis within vulnerable brain regions is still insufficiently understood. Here, we summarize the modes of action by which iron might act as primary or secondary disease trigger in neurodegenerative disorders. In addition, available treatment options targeting brain iron dysregulation and the use of iron as biomarker in prodromal stages are critically discussed to address the question of cause or consequence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–226 of 226
Peters, D. G., Pollack, A. N., Cheng, K. C., Sun, D., Saido, T. C., Haaf, M., Yang, Q. X., Connor, J. R., & Meadowcroft, M. D. (2018) · Metallomics · doi:10.1039/c8mt00004b · Cited by 45
Patel, D., Xu, C., Nagarajan, S., Liu, Z., Hemphill, W. O., Shi, R., Uversky, V. N., Caldwell, G. A., Caldwell, K. A., & Witt, S. N. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy059 · Cited by 45
Waller, R., Murphy, M., Garwood, C. J., Jennings, L. R., Heath, P. R., Chambers, A., Matthews, F. E., Brayne, C., Ince, P. G., Wharton, S. B., et al. (2018) · Glia · doi:10.1002/glia.23465 · Cited by 45
Faucheux, B. A., Herrero, M. T., Villares, J., Lévy, R., Javoy-Agid, F., Obeso, J. A., Hauw, J., Agid, Y., & Hirsch, É. C. (1995) · Brain Research · doi:10.1016/0006-8993(95)00629-5 · Cited by 43
Consequences of Iron Accumulation in Microglia and its Implications in Neuropathological Conditions
Rathnasamy, G., Ling, E., & Kaur, C. (2013) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/18715273113126660169 · Cited by 41
The history of the research of iron in parkinsonian substantia nigra
Friedman, A., & Gałązka-Friedman, J. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-012-0894-8 · Cited by 39
Zhang, H.-Y., Song, N., Jiang, H. F., Bi, M., & Xie, J. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.09.010 · Cited by 39
Iron in Friedreich Ataxia: A Central Role in the Pathophysiology or an Epiphenomenon?
Alsina, D., Purroy, R., Ros, J., & Tamarit, J. (2018) · Pharmaceuticals · doi:10.3390/ph11030089 · Cited by 38
Expression and localization of lactotransferrin messenger RNA in the cortex of Alzheimer's disease
An, L., Sato, H., Konishi, Y., Walker, D. G., Beach, T. G., Rogers, J., & Tooyama, I. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.01.071 · Cited by 37
Yu, X., Song, N., Guo, X., Jiang, H. F., Zhang, H., & Xie, J. (2016) · Scientific Reports · doi:10.1038/srep24200 · Cited by 37
Considerations for measuring iron in post-mortem tissue of Parkinson’s disease patients
Hare, D. J., Gerlach, M., & Riederer, P. F. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-012-0898-4 · Cited by 36
Zhang, Y.-H., Raymick, J. B., Sarkar, S., Lahiri, D. K., Ray, B., Holtzman, D. M., Dumas, M., & Schmued, L. C. (2013) · Current Alzheimer Research · doi:10.2174/1567205011310050005 · Cited by 35
Sheelakumari, R., Kesavadas, C., Varghese, T., Sreedharan, R. M., Thomas, B., Verghese, J., & Mathuranath, P. S. (2017) · American Journal of Neuroradiology · doi:10.3174/ajnr.a5339 · Cited by 32
Chen, Y., Chen, W.-Y., Huang, X., Xu, Y., & Zhang, H. (2017) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.113 · Cited by 31
Biomonitorization of iron accumulation in the substantia nigra from Lewy body disease patients
Fernández, B., Ferrer, I., Gil, F., & Hilfiker, S. (2017) · Toxicology Reports · doi:10.1016/j.toxrep.2017.03.005 · Cited by 30
Yu, Q., Reale, M., Kamal, M. A., Holloway, H. W., Luo, W., Sambamurti, K., Ray, B., Lahiri, D. K., Rogers, J. T., & Greig, N. H. (2013) · Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry · doi:10.2174/1871523011312020003 · Cited by 29
Amyloid A β 42 , a promoter of magnetite nanoparticle formation in Alzheimer’s disease
Tahirbegi, I. B., Pardo, W. A., Alvira, M., Mir, M., & Samitier, J. (2016) · Nanotechnology · doi:10.1088/0957-4484/27/46/465102 · Cited by 27
Gałązka-Friedman, J., Bauminger, E. R., Szlachta, K. A., & Friedman, A. (2012) · Journal of Physics Condensed Matter · doi:10.1088/0953-8984/24/24/244106 · Cited by 26
Hamilton, J. L., ul‐haq, M. I., Creagh, A. L., Haynes, C. A., & Kizhakkedathu, J. N. (2016) · Macromolecular Bioscience · doi:10.1002/mabi.201600244 · Cited by 24
Brain regional iron contents in progressive supranuclear palsy
Lee, S. H., Lyoo, C. H., Ahn, S. J., Rinne, J. O., & Lee, M. S. (2017) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2017.09.020 · Cited by 24
Xu, X., Song, N., Wang, R., Jiang, H. F., & Xie, J. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9437-2 · Cited by 21
Effect of ferric citrate on amyloid‐beta peptides behavior
Galante, D., Cavallo, E., Perico, A., & D’Arrigo, C. (2018) · Biopolymers · doi:10.1002/bip.23224 · Cited by 21
Role of transferrin receptor 2 in hepatic accumulation of iron in patients with chronic hepatitis C
Mifuji, R., Kobayashi, Y., Ma, N., QIANG, Q. L., Urawa, N., Horiike, S., Iwasa, M., Kaito, M., Malavasi, F., & Adachi, Y. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2005.04151.x · Cited by 20
Coffey, C. E., Alston, S. R., Heinz, E. R., & Burger, P. C. (1989) · Journal of Neuropsychiatry · doi:10.1176/jnp.1.4.400 · Cited by 13
Lactoferrin in the myeloproliferative disorders: a search for granulopoietic regulator defects
Brown, R. D., RICKARD, K. A., & KRONENBERG, H. (1985) · British Journal of Haematology · doi:10.1111/j.1365-2141.1985.tb07356.x · Cited by 13
Impairment of bile salt-dependent lipase secretion in human pancreatic tumoral SOJ-6 cells
Caillol, N., Pasqualini, E., Lloubès, R., & Lombardo, D. (2000) · Journal of Cellular Biochemistry · doi:10.1002/1097-4644(20001215)79:4<583::aid-jcb70>3.0.co;2-9 · Cited by 13
Cited by
Oxidative Stress and Antioxidants in Neurodegenerative Disorders
Olufunmilayo, E. O., Gerke-Duncan, M. B., & Holsinger, R. M. D. (2023) · Antioxidants · doi:10.3390/antiox12020517 · Cited by 670
Genome-wide CRISPRi/a screens in human neurons link lysosomal failure to ferroptosis
Tian, R., Abarientos, A., Hong, J., Hashemi, S. H., Yan, R., Dräger, N., Leng, K., Nalls, M. A., Singleton, A. B., Xu, K., et al. (2021) · Nature Neuroscience · doi:10.1038/s41593-021-00862-0 · Cited by 414
Genome-wide CRISPRi/a screens in human neurons link lysosomal failure to ferroptosis
Tian, R., Abarientos, A., Hong, J., Hashemi, S. H., Yan, R., Dräger, N., Leng, K., Nalls, M. A., Singleton, A. B., Xu, K., et al. (2020) · doi:10.1101/2020.06.27.175679 · Cited by 414
Cellular Iron Metabolism and Regulation
Gao, G., Li, J., Zhang, Y., & Chang, Y.-Z. (2019) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-13-9589-5_2 · Cited by 311
Iron metabolism: pathophysiology and pharmacology
Roemhild, K., von Maltzahn, F., Weiskirchen, R., Knüchel, R., von Stillfried, S., & Lammers, T. (2021) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2021.05.001 · Cited by 302
Metadata
- Authors
- Ndayisaba, A., Kaindlstorfer, C., & Wenning, G. K.
- Venue
- Frontiers in Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2019-03-01
- Volume
- 13
- Pages
- 180-180
- ISSN
- 1662-453X (ISSN-L)
- OpenAlex
- W2920373067
- Cited by
- 298
- References
- 226
- FWCI
- 12.67
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.